TYBOURNE CAPITAL MANAGEMENT (HK) LTD – Zentalis Pharmaceuticals, Inc. Transaction History
TYBOURNE CAPITAL MANAGEMENT (HK) LTD portfolio value:
$49.85M
portfolio value
TYBOURNE CAPITAL MANAGEMENT (HK) LTD quarter portfolio value change:
-22.92%
quarter
Zentalis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.12% | -124.32K shares | -18.31M | $21.66 | 2.30M |
| Q2 2022 | share | 0.00% | 0 shares | -43.76M | $28.1 | 2.42M | |
| Q1 2022 | share | Decrease | -7.70% | -202.31K shares | -109.00M | $46.14 | 2.42M |
| Q4 2021 | share | Decrease | -1.35% | -36K shares | 43.38M | $82.68 | 2.62M |
| Q3 2021 | share | 0.00% | 0 shares | 35.80M | $66.64 | 2.66M | |
| Q2 2021 | share | 0.00% | 0 shares | 26.13M | $53.2 | 2.66M | |
| Q1 2021 | share | 0.00% | 0 shares | -22.78M | $43.39 | 2.66M | |
| Q4 2020 | share | 0.00% | 0 shares | 51.28M | $51.94 | 2.66M | |
| Q3 2020 | share | 0.00% | 0 shares | -40.84M | $32.69 | 2.66M | |
| Q2 2020 | share | Increase | 0.00% | 2.66M shares | 127.94M | $48.02 | 2.66M |